Cargando…
Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses
BACKGROUND: Amlexanox (ALX), a TBK1 inhibitor, can modulate immune responses and has anti-inflammatory properties. To investigate its role in regulating the progression of experimental autoimmune encephalomyelitis (EAE), we studied the effect of ALX on the maturation of dendritic cells (DCs) and the...
Autores principales: | Quan, Mo-Yuan, Song, Xiu-Juan, Liu, Hui-Jia, Deng, Xiao-Hong, Hou, Hui-Qing, Chen, Li-Ping, Ma, Tian-Zhao, Han, Xu, He, Xin-Xin, Jia, Zhen, Guo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396467/ https://www.ncbi.nlm.nih.gov/pubmed/30823934 http://dx.doi.org/10.1186/s12974-019-1438-z |
Ejemplares similares
-
Rescue of nonsense mutations by amlexanox in human cells
por: Gonzalez-Hilarion, Sara, et al.
Publicado: (2012) -
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
por: Korniotis, Sarantis, et al.
Publicado: (2016) -
Lineage Reprogramming of Effector Regulatory T Cells in Cancer
por: Dixon, Michael L., et al.
Publicado: (2021) -
Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell
por: Li, Xin, et al.
Publicado: (2013) -
Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)